{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:01:49Z","timestamp":1773486109889,"version":"3.50.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T00:00:00Z","timestamp":1403740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1004414","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T20:47:59Z","timestamp":1403815679000},"page":"e1004414","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance"],"prefix":"10.1371","volume":"10","author":[{"given":"Zhiqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mendel","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yate-Ching","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WenYong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"JV Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/pr.55.3.4","article-title":"Specific targeted therapy of chronic myelogenous leukemia with imatinib","volume":"55","author":"MW Deininger","year":"2003","journal-title":"Pharmacol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"R Bhatia","year":"2003","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Y Hu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"ME Gorre","year":"2001","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"NP Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"H Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"NP Shah","year":"2004","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"M Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"T O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1074\/jbc.M109.039206","article-title":"BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemia","volume":"285","author":"H Yuan","year":"2010","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2012.83","article-title":"SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells","volume":"32","author":"Z Wang","year":"2013","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/carcin\/bgr278","article-title":"Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model","volume":"33","author":"H Yuan","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chen WY, Yuan H, Wang Z (2011) De novo acquisition of BCR-ABL mutations for CML acquired resistance. In: Koschmieder S, Krug U, editors. Myeloid Leukemia: Basic Mechanisms of Leukemogenesis INTECH. pp. 69\u201384.","DOI":"10.5772\/28990"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","article-title":"All-trans-retinoic acid in acute promyelocytic leukemia","volume":"337","author":"MS Tallman","year":"1997","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"RP Warrell Jr","year":"1991","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"F Malavasi","year":"2008","journal-title":"Physiol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"JP Radich","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-06-3633","article-title":"Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection","volume":"67","author":"F Huang","year":"2007","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/1078-0432.CCR-1025-3","article-title":"Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays","volume":"10","author":"HC Kang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.onc.1210700","article-title":"High expression of DNA repair pathways is associated with metastasis in melanoma patients","volume":"27","author":"A Kauffmann","year":"2008","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","article-title":"A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9","volume":"99","author":"AB Dash","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/emboj\/20.3.350","article-title":"NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice","volume":"20","author":"E Kroon","year":"2001","journal-title":"Embo J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1158\/0008-5472.CAN-06-0458","article-title":"NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells","volume":"66","author":"A Takeda","year":"2006","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1634\/stemcells.2007-0250","article-title":"Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources","volume":"25","author":"SM Graham","year":"2007","journal-title":"Stem Cells"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/stem.5530010205","article-title":"Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis","volume":"1","author":"I Kubonishi","year":"1983","journal-title":"Int J Cell Cloning"},{"key":"ref28","first-page":"1746","article-title":"Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha","volume":"54","author":"J Drach","year":"1994","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/jcb.20745","article-title":"Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels","volume":"97","author":"TJ Lamkin","year":"2006","journal-title":"J Cell Biochem"},{"key":"ref30","first-page":"504","article-title":"Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid","volume":"5","author":"PH Wiernik","year":"1991","journal-title":"Leukemia"},{"key":"ref31","first-page":"91","article-title":"Myeloid Differentiation in Liquid Cultures of Cells from Patients with Chronic Myeloid-Leukemia - Effects of Retinoic Acid and Indomethacin","volume":"12","author":"B Nilsson","year":"1984","journal-title":"Experimental Hematology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"P Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2006.08.066","article-title":"Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38","volume":"349","author":"P Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","article-title":"Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment","volume":"105","author":"S Chu","year":"2005","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"M Schemionek","year":"2010","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","article-title":"The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence","volume":"23","author":"I Bruns","year":"2009","journal-title":"Leukemia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"H Yuan","year":"2012","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"LV Sequist","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.leu.2402718","article-title":"The role of retinoids and retinoic acid receptors in normal hematopoiesis","volume":"16","author":"SJ Collins","year":"2002","journal-title":"Leukemia"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V95.2.470","article-title":"All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells","volume":"95","author":"LE Purton","year":"2000","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-7258(97)00090-9","article-title":"Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis","volume":"76","author":"Z Chen","year":"1997","journal-title":"Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10428190400013100","article-title":"Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)","volume":"46","author":"JP Dutcher","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000068494","article-title":"Effect of retinoic acid treatment on cytogenetic remission of chronic myeloid leukaemia","volume":"109","author":"M Egyed","year":"2003","journal-title":"Acta Haematol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.leu.2400682","article-title":"A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia","volume":"11","author":"J Cortes","year":"1997","journal-title":"Leukemia"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1634\/theoncologist.1-5-305","article-title":"All-Trans-Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia","volume":"1","author":"PC Adamson","year":"1996","journal-title":"Oncologist"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","article-title":"Clinical pharmacokinetics of imatinib","volume":"44","author":"B Peng","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4049\/jimmunol.145.3.878","article-title":"CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells","volume":"145","author":"M Alessio","year":"1990","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V77.6.1218.1218","article-title":"Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells","volume":"77","author":"LW Terstappen","year":"1991","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Kapil Mehta FM, editor (2000) Human CD38 and Related Molecules: Chemical Immunology.","DOI":"10.1159\/isbn.978-3-318-00469-4"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/1042819031000060564","article-title":"Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation","volume":"44","author":"E Prus","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"RH Houtkooper","year":"2012","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2012.10.525","article-title":"Seven sirtuins for seven deadly diseases of aging","volume":"56","author":"BJ Morris","year":"2013","journal-title":"Free Radical Biology and Medicine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2013.120","article-title":"Sorting out functions of sirtuins in cancer","volume":"33","author":"M Roth","year":"2013","journal-title":"Oncogene"},{"key":"ref54","first-page":"1399","article-title":"The emerging and diverse roles of sirtuins in cancer: a clinical perspective","volume":"6","author":"H Yuan","year":"2013","journal-title":"OncoTargets & Therapy"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1947601912473826","article-title":"Emerging Roles of SIRT1 in Cancer Drug Resistance","volume":"4","author":"Z Wang","year":"2013","journal-title":"Genes Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"L Li","year":"2012","journal-title":"Cancer Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2012-11-466938","article-title":"Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells","volume":"121","author":"E Bolton-Gillespie","year":"2013","journal-title":"Blood"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"RN Damle","year":"1999","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4049\/jimmunol.166.4.2228","article-title":"Signals that initiate somatic hypermutation of B cells in vitro","volume":"166","author":"S Bergthorsdottir","year":"2001","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"F Michor","year":"2005","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","article-title":"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers","volume":"486","author":"LA Diaz Jr","year":"2012","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"K Ye","year":"2009","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pgen.1005033","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000}}],"container-title":["PLoS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1004414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T16:22:34Z","timestamp":1689351754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1004414"}},"subtitle":[],"editor":[{"given":"Marshall S.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1004414","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]}}}